PH
PHRRF.US Pharmather Holdings Ltd
- Market cap
- USD 3.19M
- P/E
- -
- P/B
- 11.58x
- ROE
- -225.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.
Is PHRRF.US undervalued?
Graham numberThe Graham number of Pharmather Holdings Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pharmather Holdings Ltd fundamental analysis
No fundamental analysis for Pharmather Holdings Ltd yet.
Pharmather Holdings Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pharmather Holdings Ltd
PharmaTher Holdings Ltd., a specialty pharmaceutical and technology company, develops, acquires, and commercializes pharmaceutical products. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It also develops KETARX, a microneedle patch, for mental health, neuro…
Full company profilePharmather Holdings Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pharmather Holdings Ltd annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | - | -2.82M | -4.10M | -4.01M | -846K | -617K |
| EBITDA | - | -2.82M | -4.10M | -4.01M | -846K | -617K |
| Net Income | - | 2.66M | -4.01M | -6.42M | -610K | -883K |
| EPS | - | 0.04 | -0.05 | -0.07 | -0.01 | -0.01 |
| Balance Sheet | ||||||
| Total Assets | - | 5.94M | 12.2M | 6.31M | 1.12M | 980K |
| Total Liabilities | - | 361K | 330K | 892K | 509K | 588K |
| Shareholders' Equity | - | 5.58M | 11.8M | 5.42M | 613K | 392K |
| Cash & Short-term Investments | - | 2.78M | 9.15M | 5.92M | 688K | 604K |
| Cash Flow | ||||||
| Operating Cash Flow | -714.00 | 922K | -3.51M | -3.24M | -485K | -337K |
| Capital Expenditure | 4.27K | 4.27K | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | 918K | -3.51M | -3.24M | -485K | -337K |
| Ratios | ||||||
| ROE | - | 47.7% | -33.9% | -118.4% | -99.6% | -225.2% |
| ROA | - | 44.8% | -33.0% | -101.7% | -54.4% | -90.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
Pharmather Holdings Ltd dividends
Pharmather Holdings Ltd has not paid dividends in the last 5 fiscal years.
Who owns Pharmather Holdings Ltd
- Insiders 18.74%
- Institutions 0.00%
- Public & others 81.26%
- Shares outstanding 91.0M
- Free float 73.5M
Pharmather Holdings Ltd company profile
- Company name
- Pharmather Holdings Ltd
- Ticker
- PHRRF.US
- ISIN
- CA71716H1082
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- May
- Address
- 82 Richmond Street East, Toronto, ON, Canada, M5C 1P1
- Phone
- 888-846-3171
- Website
- pharmather.com
About Pharmather Holdings Ltd
PharmaTher Holdings Ltd., a specialty pharmaceutical and technology company, develops, acquires, and commercializes pharmaceutical products. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. The company also develops Personaliz3D Peptides, focused on developing and commercializing personalized peptide products and protocols using 3D printing and artificial intelligence technologies. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson's disease; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Pharmather Holdings Ltd management
3- Mr. Fabio ChianelliFounder, Chairman & CEO · born 1978
- Mr. Carmelo Marrelli ACIS, B.Comm., C.A., C.P.A., CGAChief Financial Officer · born 1971
- Mr. Andrew ToddCorporate Secretary · born 1957